NEW YORK – A team from the Broad Institute, the Massachusetts Institute of Technology, Memorial Sloan Kettering Cancer Center, and elsewhere has outlined progress made so far on the Human Tumor Atlas Network (HTAN), an effort to follow cancer development, progression, and treatment response over time using a series of single-cell atlases.